Domenica Scumaci

Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs

Domenico Iacopetta, Jessica Ceramella, Alessia Catalano et al. · Applied Sciences · 2023 · 62 citations · Full text

Molecular Pharmacology, Biochemistry, Physiologically-based Pharmacokinetic Modeling +13

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression<i>in vitro</i>and<i>in vivo</i>and synergizes with radiotherapy

Cristina Talarico, Lucia D’Antona, Domenica Scumaci et al. · Oncotarget · 2015 · 61 citations · Full text

Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells

Rosario Amato, Domenica Scumaci, Lucia D’Antona et al. · Oncogene · 2012 · 57 citations · Full text

Cancer Research, Signal Transduction, Signaling Pathway +12

Interaction of β-lactam antibiotics with the mitochondrial carnitine/acylcarnitine transporter

Lorena Pochini, Michele Galluccio, Domenica Scumaci et al. · Chemico-Biological Interactions · 2008 · 48 citations

Molecular Pharmacology, Biochemistry, Medicine +4

miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma

Marco Rossi, Emanuela Altomare, Cirino Botta et al. · Leukemia · 2020 · 45 citations

Tumor Biology, Mir-21 Antagonism, Medicine +7